Scimago Journal & Country Rank

EJNMMI Radiopharmacy and Chemistryopen access

Country

Switzerland

Universities and research institutions in Switzerland
Media Ranking in Switzerland

Subject Area and Category

Publisher

Springer Science and Business Media Deutschland GmbH

H-Index

28

Publication type

Journals

ISSN

2365421X

Coverage

2016-2023

Information

Homepage

How to publish in this journal

Scope

EJNMMI Radiopharmacy and Chemistry publishes new research in the field of development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists and basic scientists to present their views and scientific work. In addition, the journal provides insight into novel concepts of imaging or radionuclide-based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on the application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in the form of guidelines or position papers. Join the conversation about this journal
Quartiles

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

CategoryYearQuartile
Analytical Chemistry2021Q2
Analytical Chemistry2022Q1
Analytical Chemistry2023Q1
Pharmacology2021Q3
Pharmacology2022Q1
Pharmacology2023Q2
Pharmacology (medical)2021Q3
Pharmacology (medical)2022Q1
Pharmacology (medical)2023Q2
Radiology, Nuclear Medicine and Imaging2021Q3
Radiology, Nuclear Medicine and Imaging2022Q1
Radiology, Nuclear Medicine and Imaging2023Q1
SJR

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

YearSJR
20210.447
20220.972
20230.869
Total Documents

Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents.

YearDocuments
201613
201716
201814
201931
202031
202135
202233
202342
Citations per document

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Cites per documentYearValue
Cites / Doc. (4 years)20160.000
Cites / Doc. (4 years)20172.462
Cites / Doc. (4 years)20182.172
Cites / Doc. (4 years)20192.884
Cites / Doc. (4 years)20203.392
Cites / Doc. (4 years)20214.728
Cites / Doc. (4 years)20224.613
Cites / Doc. (4 years)20234.685
Cites / Doc. (3 years)20160.000
Cites / Doc. (3 years)20172.462
Cites / Doc. (3 years)20182.172
Cites / Doc. (3 years)20192.884
Cites / Doc. (3 years)20203.098
Cites / Doc. (3 years)20214.868
Cites / Doc. (3 years)20225.031
Cites / Doc. (3 years)20234.020
Cites / Doc. (2 years)20160.000
Cites / Doc. (2 years)20172.462
Cites / Doc. (2 years)20182.172
Cites / Doc. (2 years)20192.267
Cites / Doc. (2 years)20203.178
Cites / Doc. (2 years)20215.258
Cites / Doc. (2 years)20224.500
Cites / Doc. (2 years)20233.588
Total Cites 
Self-Cites

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

CitesYearValue
Self Cites20160
Self Cites20172
Self Cites201815
Self Cites20196
Self Cites20209
Self Cites202132
Self Cites202236
Self Cites202339
Total Cites20160
Total Cites201732
Total Cites201863
Total Cites2019124
Total Cites2020189
Total Cites2021370
Total Cites2022488
Total Cites2023398
External Cites per Doc 
Cites per Doc

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

CitesYearValue
External Cites per document20160
External Cites per document20172.308
External Cites per document20181.655
External Cites per document20192.744
External Cites per document20202.951
External Cites per document20214.447
External Cites per document20224.660
External Cites per document20233.626
Cites per document20160.000
Cites per document20172.462
Cites per document20182.172
Cites per document20192.884
Cites per document20203.098
Cites per document20214.868
Cites per document20225.031
Cites per document20234.020
% International Collaboration

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

YearInternational Collaboration
201646.15
201731.25
201821.43
201935.48
202035.48
202131.43
202245.45
202340.48
Citable documents 
Non-citable documents

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

DocumentsYearValue
Non-citable documents20160
Non-citable documents20172
Non-citable documents20185
Non-citable documents20195
Non-citable documents20206
Non-citable documents20213
Non-citable documents20225
Non-citable documents20234
Citable documents20160
Citable documents201711
Citable documents201824
Citable documents201938
Citable documents202055
Citable documents202173
Citable documents202292
Citable documents202395
Cited documents 
Uncited documents

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

DocumentsYearValue
Uncited documents20160
Uncited documents20173
Uncited documents20187
Uncited documents201912
Uncited documents202016
Uncited documents202111
Uncited documents202219
Uncited documents202325
Cited documents20160
Cited documents201710
Cited documents201822
Cited documents201931
Cited documents202045
Cited documents202165
Cited documents202278
Cited documents202374
Scimago Journal & Country Rank
Show this widget in your own website

Just copy the code below and paste within your html code:
SCImago Graphica
Explore, visually communicate and make sense of data with our new data visualization tool.
Metrics based on Scopus® data as of March 2024
Loading comments…

Leave a comment

* Required

* Required

* Required

* Required

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Developed by:
Scimago Lab
Powered by:
Powered by scopus

Follow us on @ScimagoJR

Scimago Lab, Copyright 2007-2024. Data Source: Scopus®

Legal Notice

Privacy Policy